Skip to content
  • HOME
  • ABOUT US
    • What We Do
    • Team
    • Former Members
    • Community News
  • PROJECTS
    • Upcoming and Previous
    • Example Case Study
    • Consulting FAQs
  • EVENTS
  • COMMUNICATIONS
    • Viewpoints
    • Market Reports
  • DIVERSITY
    • Our Statement
    • Action Items
    • Get Involved

T Cell Engineering: Crafting Cellular Warriors Against Cancer

by Dr. Mehdi Soleymani Goloujeh | October 11th, 2024

Introduction to the Challenge of Cancer Cancer is one of the major global health issues, with its incidence steadily increasing and mortality rates on the rise, affecting millions of people each year. In 2022, approximately 20 million new cancer cases and nearly 9.7 million cancer-related deaths were reported worldwide. By 2050, cancer cases are projected […]

Read More

From Pandemics to Progress: A Survey of Venture Capital Investments in Infectious Disease

by Nicole Tanenbaum | October 11th, 2024

From the blow of the Black Death in medieval Europe, to the polio epidemics of the 20th century, and the widespread devastation caused by smallpox, pathogens have continually caused widespread morbidity and mortality. Today, several of these microbes feel like threats of the past. With advancements in controlling infectious diseases, vaccine-preventable deaths have dropped and […]

Read More

The fight against the silent pandemic: a synergistic effort for combating antimicrobial resistance

by Kristel C. Tjandra, PhD | May 23, 2022

The world is running out of weapons to fight against the threat of superbugs. A collective effort from healthcare, government, and industry is needed.  

Read More

Lessons from microbial growing pains

by Andrew Saintsing | December 22, 2021

While our society has grown accustomed to microbe-produced medicines like penicillin and insulin, biotechnology startups today, especially those in the San Francisco Bay Area, are increasingly looking to use these microscopic chemists in industries beyond pharmaceuticals. 

Read More

Taking the high road: turning to drugs to treat addiction

by Alyssa DiLeo | December 22, 2021

Researchers are once again pursuing psychedelic drugs as potential treatments for neuropsychiatric disorders, such as substance use disorder. This comes at a crucial time when drug use and overdose deaths have increased during the ongoing COVID-19 pandemic.

Read More

Could collaborative biotech teams close the gap in cancer research?

by Jessica Maldonado-Mendoza, PhD | December 14, 2021

By 2040, cancer cases are expected to significantly rise in Latin America and Asia. But a lack of technology, trained personnel, funding, and diminished participation interfere with scientists’ fight against cancer in these regions.

Read More

Toward an equitable and inclusive science communication landscape

by Kelly Montgomery | June 16th, 2021

As scientists push to reach broader audiences and better communicate the science behind their leading technologies, there has been an uptick in the market supporting the emerging business of scientific communication. Organizations are coming to realize that effective communication between companies and their stakeholders, including investors, policymakers, and the general public is critical to their […]

Read More

Science trainees, have you considered a career in technology transfer?

by Nnamdi Nelson, PhD | May 29th, 2021

When I was younger, I regularly watched science documentaries and was inspired by how scientific breakthroughs could improve lives. Over the years, my admiration for scientists and the scientific process grew and led me to pursue a graduate degree in neuroscience. As I continue on my educational journey and training, I’ve realized that it takes […]

Read More

Privacy vs Public Health: How can we use patient data for societal good?

by Navya Pothamsetty, MPH | May 11th, 2021

From Netflix’s The Social Dilemma and scandals like Facebook’s Cambridge Analytica partnership, there’s no shortage of media warnings against user data collection. The news is flooded with stories covering the way companies collect, store, and sell our data as we shop, play, and socialize online. Most of these narratives underscore the ways companies profit from […]

Read More

Modern Solutions for the Agriculture Industry Using CRISPR Gene Editing

by Cally Xiao, PhD | May 11th, 2021

About 10,000 years ago, […] Sapiens began to devote almost all their time and effort to manipulating the lives of a few animal and plant species. From sunrise to sunset humans sowed seeds, watered plants, plucked weeds from the ground and led sheep to prime pastures. This work, they thought, would provide them with more […]

Read More

Next »

To learn more about how BCBA can
help your business or organization,
please contact us at info@biotechconnectionbay.org

2025 © Biotech Connection - Bay Area, Inc., All Rights Reserved

Biotech Website Design by Thomas Digital

  • HOME
  • ABOUT US
    • What We Do
    • Team
    • Former Members
    • Community News
  • PROJECTS
    • Upcoming and Previous
    • Example Case Study
    • Consulting FAQs
  • EVENTS
  • COMMUNICATIONS
    • Viewpoints
    • Market Reports
  • DIVERSITY
    • Our Statement
    • Action Items
    • Get Involved